This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

ORIX USA Launches ORIX USA Health And Life Sciences LLC With CEO John Amos At The Helm

ORIX USA has created a new business unit specializing in the healthcare and life sciences sectors; seasoned industry veteran John Amos has joined ORIX Health and Life Sciences as CEO.

ORIX Health and Life Sciences will invest in operating companies within the sector and stimulate the growth of the companies through acquisitions, capital and operating assistance from ORIX USA.

ORIX USA is a Dallas, Texas-based diversified financial conglomerate with both direct investment portfolios and ownership of operating subsidiaries in investment banking (Houlihan Lokey), multifamily mortgage lending (RED Capital Group) and asset management (Mariner Investment Group). With Health and Life Sciences, ORIX USA will expand its portfolio of operating companies into healthcare, a large and growing sector of the economy.

“As with previous acquisitions including Houlihan Lokey, RED Capital Group and Mariner Investment Group, our interest is in businesses with strong management teams, which will be maintained as separate entities under ORIX USA’s governance and supported by our investment capital,” said ORIX USA CEO Jim Thompson. “With the launch of ORIX USA Health and Life Sciences, this strategy is broadening from financial firms to the healthcare sector.”

CEO John Amos has a strong background in operating health care companies having worked at both McKesson and Bristol Meyer. As CEO of Oncology Therapeutic Networks (OTN), Amos grew OTN through a string of successfully executed acquisitions before selling it to McKesson Corporation. Amos also has served on the boards of Apollo Health Street, Prodigy Health, Navigating Cancer, CITIC Pharmaceuticals, Aesyntix Health and as the venture partner for Bioveda China Fund.

About ORIX USA

ORIX USA is a diversified financial company with more than $5 billion of assets in sectors spanning commercial finance, venture finance, commercial real estate, mortgage backed securities and public finance. Operating subsidiaries include Houlihan Lokey, Mariner Investment Group and RED Capital Group. Headquartered in Dallas Texas, ORIX USA and its subsidiaries have approximately 1,400 employees, $25 billion of assets managed for others and offices in most major cities including New York, Los Angeles, Milwaukee, Atlanta as well as Hong Kong and Tokyo.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,199.52 -14.90 -0.08%
S&P 500 2,109.96 -0.78 -0.04%
NASDAQ 4,982.3190 -5.5710 -0.11%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs